Study: MYC-Targeting Inhibitors Generated from a Stereodiversified Bicyclic Peptide Library.Image Credit: Christoph Burgstedt / Shutterstock.com. Targeting MYC. MYC, a transcription factor ...

By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene - a well-known cancer-causing gene ...

Pioneered by Dr. Chidiebere Awah MD, PhD, our CEO and Principal Investigator, UTRxM1-18 targets oncogenic c-MYC by recognizing specific motifs and switching the ribosome machinery from a ...

Pimera has partnered with The Australian National University (ANU) to lead the research. The Phase 1a/b trial, which is funded by the Medical Research Future Fund (MRFF), targets MYC-driven ...